These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30377853)

  • 1. Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer.
    Hiramoto S; Tamaki T; Nagashima K; Hori T; Kikuchi A; Yoshioka A; Inoue A
    Int J Clin Oncol; 2019 Apr; 24(4):454-459. PubMed ID: 30377853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
    Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
    Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status.
    Fiorin de Vasconcellos V; Rcc Bonadio R; Avanço G; Negrão MV; Pimenta Riechelmann R
    BMC Palliat Care; 2019 May; 18(1):42. PubMed ID: 31109330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative Chemotherapy Near the End of Life in Oncology Patients.
    Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
    Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of sudden unexpected death in patients with advanced cancer near the end of life.
    Taniyama T; Tokutani R; Hiramoto S
    Palliat Support Care; 2022 Dec; 20(6):818-822. PubMed ID: 34607625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-of-Life Care Intensity Among Adolescent and Young Adult Patients With Cancer in Kaiser Permanente Southern California.
    Mack JW; Chen LH; Cannavale K; Sattayapiwat O; Cooper RM; Chao CR
    JAMA Oncol; 2015 Aug; 1(5):592-600. PubMed ID: 26181778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of molecular targeting agents and immune-checkpoint inhibitors in patients with advanced cancer who are near the end of life.
    Hiramoto S; Taniyama T; Kikuchi A; Hori T; Yoshioka A; Inoue A
    Palliat Support Care; 2021 Dec; 19(6):709-714. PubMed ID: 33729120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
    Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.
    Chen ML; Chen YY; Tang ST
    Eur J Cancer; 2013 Oct; 49(15):3284-91. PubMed ID: 23756054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer.
    Zhu Y; Tang K; Zhao F; Zang Y; Wang X; Li Z; Sun X; Yu J
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1591-1599. PubMed ID: 29845418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
    Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
    Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.
    Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
    Lopez-Acevedo M; Havrilesky LJ; Broadwater G; Kamal AH; Abernethy AP; Berchuck A; Alvarez Secord A; Tulsky JA; Valea F; Lee PS
    Gynecol Oncol; 2013 Jul; 130(1):156-61. PubMed ID: 23587882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy in the last 30 days of life of advanced cancer patients.
    Pacetti P; Paganini G; Orlandi M; Mambrini A; Pennucci MC; Del Freo A; Cantore M
    Support Care Cancer; 2015 Nov; 23(11):3277-80. PubMed ID: 25900109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
    Balu S; Buchner D; Craver C; Gayle J
    Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer.
    Sim SH; Kim YJ; Kim SH; Keam B; Kim TM; Lee SH; Kim DW; Heo DS; Lee JS
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1073-81. PubMed ID: 25410789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy Use at the End of Life in Uganda.
    Low D; Merkel EC; Menon M; Lyman GH; Ddungu H; Namukwaya E; Leng M; Casper C
    J Glob Oncol; 2017 Dec; 3(6):711-719. PubMed ID: 29244988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
    Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
    Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer.
    Tsai MY; Hung YC; Chen YH; Chen YH; Huang YC; Kao CW; Su YL; Chiu HH; Rau KM
    BMC Complement Altern Med; 2016 Aug; 16(1):322. PubMed ID: 27565426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.